FY2026
Effective from
- Code-level rules changed
Plasminogen deficiency
Billable diagnosis code
CDC/NCHS · FY2026, if applicable, ligneous conjunctivitis (H10.51-)
codes for associated conditions
histiocytosis X (chronic) (C96.6)
Ehlers-Danlos syndromes (Q79.6-)
disorder of lipoprotein metabolism (E78.-)
Coverage depends on the payer, service and applicable policy. A billable code does not guarantee payment.
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2018-10-01
Latest recorded change · FY2026
Effective from
Plasminogen deficiency
Billable diagnosis code
CDC/NCHS · FY2026| All editions | Effective from | Code history |
|---|---|---|
| FY2019 | 2018-10-01 | Added |
| FY2020 | 2019-10-01 | Code-level rules changed · Inherited rules changed |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | Inherited rules changed |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | Inherited rules changed |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | Inherited rules changed |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | Inherited rules changed |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | Code-level rules changed |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
, if applicable, ligneous conjunctivitis (H10.51-)
histiocytosis X (chronic) (C96.6)
codes for associated conditions
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Ehlers-Danlos syndromes (Q79.6-)
disorder of lipoprotein metabolism (E78.-)
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Previous assignment: E88.09
Other entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| E88.01 | Alpha-1-antitrypsin deficiency | Billable / specific |
| E88.09 | Other disorders of plasma-protein metabolism, not elsewhere classified | Billable / specific |
Official titles and instructions are preserved in their source language. Official sources ↗
Code first · plasminogen deficiency (E88.02)
Code also · plasminogen deficiency (E88.02)
Code first · plasminogen deficiency (E88.02)
Code first · plasminogen deficiency (E88.02)